Skip to main content
. 2024 Dec 16;77(6):e20240189. doi: 10.1590/0034-7167-2024-0189

Table 1. Sociodemographic and clinical characteristics of newborns undergoing percutaneous catheterization, Curitiba, Paraná, Brazil, 2023.

Variable Control Group
(n=56)
Experimental Group
(n=55)
p *
n (%) Median
(95%CI)
n (%) Median
(95%CI)
Gestational age at birth (weeks) 36 (34-38) 36 (33-38) 0.785 1
Age at insertion (days) 36 (23-43) 29 (11-59) 0.797 1
Birth weight (grams) 2268 (1650-2780) 2355 (1420-2755) 0.969 1
SNAPPE II scale ** 8 (5-15) 5 (5-15) 0.255 1
DIVA score *** ≥ 4 34 (48.6) 36 (51.4) 0.605 2
Catheter indication 0.773 2
Therapy incompatible with peripheral route 48 (49.0) 50 (51.0)
Therapy ≥ 7 days 10 (47.6) 11 (52.4)
Difficult venous access 37 (48.7) 39 (51.3)
Diagnosis that culminated in catheter insertion 0.497 2
Infectious and parasitic diseases 16 (48.5) 17 (51.5)
Disorders of other endocrine glands 1 (100.0) 0 (0.0)
Diseases of the nervous system 1 (33.3) 2 (66.7)
Diseases of the respiratory system 5 (50.0) 5 (50.0)
Diseases of the digestive system 3 (37.5) 5 (62.5)
Diseases of the genitourinary system 2 (66.7) 1 (33.3)
Conditions originating in the neonatal period 24 (60.0) 16 (40.0)
Congenital malformations, deformities and chromosomal anomalies 4 (28.6) 10 (71.4)

n - numberof participants;

*

p - <0.05,

**

SNAPPE - Score for Neonatal Acute Physiology Perinatal Extension,

***

DIVA - Difficult Intravenous Access; p value -

1

Kruskal-Wallis,

2

Pearson’schi-square.